
Thomas Neff, FibroGen
FibroGen founder and CEO Thomas Neff dies unexpectedly as lead drug nears commercial threshold
FibroGen founder and CEO Thomas Neff died “unexpectedly” over the weekend, says the biotech company.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters